Is There a Relationship between Adverse Pregnancy Outcomes and Future Development of Atherosclerosis?

Anastasia V Poznyak1, Victoria A Khotina2, Elena B Zhigmitova2

  • 1Institute for Atherosclerosis Research, Osennyaya 4-1-207, 121609 Moscow, Russia.

Biomedicines
|September 28, 2023
PubMed

Insights

Adverse pregnancy outcomes like gestational diabetes and hypertensive disorders are linked to later cardiovascular disease. Understanding these connections can reveal crucial gender-specific risk factors for atherosclerosis.

Area of Science:

  • Reproductive endocrinology and cardiovascular medicine.

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality.
  • Early identification of CVD risk factors is crucial for effective management and prevention of atherosclerosis.
  • Adverse pregnancy outcomes affect over 30% of women and are increasingly recognized as potential indicators of future cardiovascular risk.

Purpose of the Study:

  • To review the association between adverse pregnancy outcomes and the development of atherosclerotic cardiovascular disease.
  • To explore the underlying mechanisms linking conditions such as gestational diabetes, hypertensive disorders of pregnancy, miscarriages, and stillbirths to female cardiovascular health.
  • To identify potential gender-specific risk factors for cardiovascular disease originating from pregnancy complications.

Main Methods:

  • Systematic review of recent scientific literature.
  • Analysis of data from studies investigating the pathophysiological links between specific pregnancy disorders and cardiovascular system implications.
  • Focus on mechanisms underlying gestational diabetes, hypertensive disorders of pregnancy, miscarriages, and stillbirths.

Main Results:

  • Evidence suggests a significant correlation between adverse pregnancy outcomes and an increased risk of postpartum cardiovascular disease.
  • Specific pregnancy complications share underlying mechanisms that contribute to the development of atherosclerosis.
  • These conditions may serve as early indicators of cardiovascular risk in women.

Conclusions:

  • Adverse pregnancy outcomes represent a critical window for assessing long-term cardiovascular health in women.
  • Understanding the shared pathways between pregnancy complications and atherosclerosis can lead to improved cardiovascular risk stratification and targeted interventions.
  • Further research into gender-specific cardiovascular risk factors stemming from pregnancy is warranted.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
46
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12